Establishes New Jersey Active Pharmaceutical Ingredient Regulatory Commission.

S 2894 creates the New Jersey Active Pharmaceutical Ingredient Regulatory Commission to oversee the manufacturing of active pharmaceutical ingredients (APIs) within the state and ensure quality standards for APIs used in New Jersey, regardless of where they're manufactured. The commission, composed of 17 members including pharmaceutical industry experts, state health and economic development officials, and non-voting legislative representatives, will establish manufacturing standards, promote API industry growth using federal funding, and serve as a liaison between the pharmaceutical sector and state/federal governments. It operates independently of the Department of the Treasury despite being allocated there, and will adopt rules under the Administrative Procedure Act to carry out its duties. This bill directly affects pharmaceutical manufacturers in New Jersey and those using imported APIs sold within the state.